Announcements Trials
Browse Landscape

Phase

Phase NA 10Phase 2 2Phase 3 1

Status

Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Thoracic 1Gynecologic 1

Conditions

Motor Activity 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms 1

Interventions

Trastuzumab 349Paclitaxel 310Cyclophosphamide 286Docetaxel 267Carboplatin 215Capecitabine 214Letrozole 185Fulvestrant 178Doxorubicin 166Bevacizumab 136Anastrozole 120Tamoxifen 117pertuzumab 114pembrolizumab 113Epirubicin 110exemestane 107Vinorelbine 106Gemcitabine 106Albumin-Bound Paclitaxel 92Lapatinib 84130-nm albumin-bound paclitaxel 83Radiotherapy 79palbociclib 75eribulin 73Cisplatin 69pyrotinib 66Taxes 65Everolimus 55Goserelin 50Drug Therapy 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Nutrition Assessment × Breast × Clear all
NCT01621659 2026-05-11

TITAN

University of Alberta

Phase 2 Active not recruiting
80 enrolled
Breast

Breast Neoplasms, Motor Activity

NCT05023967 2026-01-05

Metformin and Nightly Fasting in Women With Early Breast Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
120 enrolled
Breast

Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡